The Movember Global Action Plan 1 (GAP1) - Unique Prostate Cancer Tissue Microarray Resource

Véronique Ouellet, Andrew Erickson, Kathy Wiley, Colm Morrissey, Viktor Berge, Carlos S. Moreno, Kristin Austlid Tasken, Dominique Trudel, Lawrence D. True, Michael S. Lewis, Aud Svindland, Onur Ertunc, Igor Damasceno Vidal, Adeboye O. Osunkoya, Tracy Jones, G. Steven Bova, Tarja Lamminen, Ariel H. Achtman, Mark Buzza, Michelle M Kouspou, GAP1 UTMAs Contributing Investigators, Steven A Bigler, Xinchun Zhou, Stephen J. Freedland, Anne-Marie Mes-Masson, Isla P. Garraway, Bruce J. Trock, Pekka Taimen, Fred Saad, Tuomas Mirtti, Beatrice S. Knudsen, Angelo M. De Marzo
doi: https://doi.org/10.1101/2021.06.03.21256653

Article Information

doi 
https://doi.org/10.1101/2021.06.03.21256653
History 
  • June 4, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Véronique Ouellet1,*,
  2. Andrew Erickson2,3,4,*,
  3. Kathy Wiley4,
  4. Colm Morrissey5,
  5. Viktor Berge6,
  6. Carlos S. Moreno7,8,
  7. Kristin Austlid Tasken9,10,
  8. Dominique Trudel1,11,
  9. Lawrence D. True12,
  10. Michael S. Lewis13,
  11. Aud Svindland10,14,
  12. Onur Ertunc15,
  13. Igor Damasceno Vidal4,
  14. Adeboye O. Osunkoya7,8,
  15. Tracy Jones15,
  16. G. Steven Bova16,
  17. Tarja Lamminen17,
  18. Ariel H. Achtman18,
  19. Mark Buzza18,
  20. Michelle M Kouspou19,
  21. GAP1 UTMAs Contributing Investigators,
  22. Steven A Bigler19,
  23. Xinchun Zhou20,
  24. Stephen J. Freedland21,
  25. Anne-Marie Mes-Masson1,22,
  26. Isla P. Garraway23,24,
  27. Bruce J. Trock25,
  28. Pekka Taimen26,27,
  29. Fred Saad1,28,**,
  30. Tuomas Mirtti29,30,**,
  31. Beatrice S. Knudsen31,** and
  32. Angelo M. De Marzo4,25,32,**,#
  1. 1Centre de recherche du Centre hospitalier de l’Université de Montréal et Institut du cancer de Montréal, Montreal, Canada
  2. 2Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK
  3. 3Department of Pathology, Helsinki and Uusimaa Hospital District and Medicum, University of Helsinki, Helsinki, Finland
  4. 4Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
  5. 5Department of Urology, University of Washington, Seattle, Washington
  6. 6Department of Urology, Oslo University Hospital, Oslo, Norway
  7. 7Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia
  8. 8Winship Cancer Institute of Emory University, Atlanta, Georgia
  9. 9Institute of Cancer Research, Oslo University Hospital, Oslo, Norway
  10. 10Institute of Clinical Medicine, University of Oslo, Oslo, Norway
  11. 11Department of Pathology and Cellular Biology, Université de Montréal, Montreal, Canada
  12. 12Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington
  13. 13West Los Angeles Veterans Affairs Medical Center and Departments of Pathology and Medicine, Cedars-Sinai Medical Center, Los Angeles, California
  14. 14Department of Pathology, Oslo University Hospital, Oslo, Norway
  15. 15Suleyman Demirel University, Department of Pathology, Training and Research Hospital East Campus, 32260, Isparta/Turkey
  16. 16Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, Tampere, FI-33014, Finland
  17. 17Institute of Biomedicine, University of Turku, Turku, Finland
  18. 18Movember, Melbourne, Australia
  19. 19Department of Pathology, Mississippi Baptist Medical Center, Jackson, Mississippi, USA
  20. 20Department of Pathology, University of Mississippi Medical Center, Jackson, Mississippi, USA
  21. 21Center for Integrated Research on Cancer and Lifestyle, Cedars-Sinai Medical Center, Los Angeles, California
  22. 22Department of Medecine, Université de Montréal, Montreal, Canada
  23. 23Department of Urology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California, Los Angeles, California
  24. 24Division of Urology, Greater Los Angeles VA Healthcare System. Department, Los Angeles, California
  25. 25Department of Urology and Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland
  26. 26Institute of Biomedicine, University of Turku, Turku, Finland
  27. 27Department of Pathology, Turku University Hospital, Turku, Finland
  28. 28Department of Surgery, Université de Montréal, Montreal, Canada
  29. 29HUS Diagnostic Center, Dept. of Pathology, HUS Helsinki University Hospital, Helsinki, Finland
  30. 30Medicum and Research Program In Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland
  31. 31Digital and Computational Pathology, University of Utah, Salt Lake City, Utah
  32. 32Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  1. ↵#Corresponding author:
    Angelo M. De Marzo MD PhD, Department of Pathology, 1550 Orleans Street, CRB2, Rm 144, Baltimore, Maryland 21231, 410-614-5686 T, 410-502-9817 F; email: ademarz{at}jhmi.edu
    1. aCentre de recherche du Centre hospitalier de l’Université de Montréal et Institut du cancer de Montréal, Montreal, Canada
    2. bDepartment of Urology, Turku University Hospital, Turku, Finland
    3. cMovember, Melbourne, Australia
    4. dEmory University, Atlanta, Georgia
    5. eCedars-Sinai Medical Center, Los Angeles, California
    6. fBrady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland
    7. gHUS Helsinki University Hospital, Dept of Urology, Helsinki, Finland. Research Program In Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland
    8. hMedicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland
    9. iDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland

    1. ↵* These authors contributed equally to first authorship

    2. ↵** These authors contributed equally to senior authorship

    Back to top
    Posted June 04, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email
    The Movember Global Action Plan 1 (GAP1) - Unique Prostate Cancer Tissue Microarray Resource
    Véronique Ouellet, Andrew Erickson, Kathy Wiley, Colm Morrissey, Viktor Berge, Carlos S. Moreno, Kristin Austlid Tasken, Dominique Trudel, Lawrence D. True, Michael S. Lewis, Aud Svindland, Onur Ertunc, Igor Damasceno Vidal, Adeboye O. Osunkoya, Tracy Jones, G. Steven Bova, Tarja Lamminen, Ariel H. Achtman, Mark Buzza, Michelle M Kouspou, GAP1 UTMAs Contributing Investigators, Steven A Bigler, Xinchun Zhou, Stephen J. Freedland, Anne-Marie Mes-Masson, Isla P. Garraway, Bruce J. Trock, Pekka Taimen, Fred Saad, Tuomas Mirtti, Beatrice S. Knudsen, Angelo M. De Marzo
    medRxiv 2021.06.03.21256653; doi: https://doi.org/10.1101/2021.06.03.21256653
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools

    Subject Area